Predicting Outcome in Combination Treatment of TACE and Camrelizumab for Advanced Hepatocellular carcinoma: Tumor Hypervascularity and Reactive Cutaneous Capillary Endothelial Proliferation

OBJECTIVE: To validate the robust predictive values of tumor vascularity and reactive cutaneous capillary endothelial proliferation (RCCEP) in combination treatment of transarterial chemoembolization (TACE) and camrelizumab for patients with advanced hepatocellular carcinoma (HCC) and then select th...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Liang, Liu, Kai-Cai, Lv, Wei-Fu, Xu, Shao-Bao, Lu, Dong, Zhou, Chun-Ze, Cheng, De-Lei, Gao, Zong-Gen, Shi, Chang-Sheng, Su, Ming-Xue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531610/
https://www.ncbi.nlm.nih.gov/pubmed/36203820
http://dx.doi.org/10.2147/DDDT.S372276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531610/
https://www.ncbi.nlm.nih.gov/pubmed/36203820
http://dx.doi.org/10.2147/DDDT.S372276

Ejemplares similares